- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Symptomatic multiple myeloma
I alt 14455 resultater
-
Washington University School of MedicineKaryopharm Therapeutics IncRekrutteringMyelomatose | Myelom-associeret amyloidoseForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)RekrutteringPlasmacellemyelom | ISS Stage III PlasmacellemyelomForenede Stater
-
Memorial Sloan Kettering Cancer CenterPentixapharm AGRekrutteringMyelomatose | Non-Hodgkin lymfom | Erdheim-Chesters sygdom | Rosai-Dorfmans sygdom | Histiocytiske neoplasmerForenede Stater
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRekruttering
-
Nantes University HospitalCyceronIkke rekrutterer endnu
-
Hackensack Meridian HealthJanssen, LPAfsluttetMyelomatoseForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAmyloidose | PlasmacellemyelomForenede Stater
-
TakedaAfsluttetRecidiverende og/eller refraktært myelomatose (RRMM)Forenede Stater, Canada
-
Mayo ClinicNational Cancer Institute (NCI)AfsluttetTilbagevendende plasmacellemyelomForenede Stater
-
University of ChicagoAktiv, ikke rekrutterendeMyelomatoseForenede Stater, Polen
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHAktiv, ikke rekrutterendeTidligere ubehandlet symptomatisk myelomatoseTyskland
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...AfsluttetMyelomatoseForenede Stater
-
University of Illinois at ChicagoAfsluttetMyelom, tilbagefald | Myelom, refraktær til standardbehandlingForenede Stater
-
CelgeneAfsluttet
-
University of PennsylvaniaAfsluttet
-
University Hospital HeidelbergGerman Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... og andre samarbejdspartnereAfsluttet
-
University Hospital, LilleAmgenUkendt
-
University of Illinois at ChicagoAfsluttetMyelomatoseForenede Stater
-
National Cancer Institute (NCI)AfsluttetDS Stadie I Plasmacellemyelom | DS Stage II Plasmacellemyelom | DS trin III PlasmacellemyelomForenede Stater
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneAfsluttet
-
University of MiamiAfsluttetMyelomatoseForenede Stater
-
Hospira, now a wholly owned subsidiary of PfizerAfsluttetMyelomatose | Faste tumorer | Maligne lymfomer | Kemoterapi-induceret symptomatisk anæmiTyskland
-
Ohio State University Comprehensive Cancer CenterAfsluttetMyelomatoseForenede Stater
-
Grupo de Estudos Multicentricos em Onco-HematologiaUkendt
-
University Hospital, BordeauxAfsluttet
-
The First Affiliated Hospital of Soochow UniversityIkke rekrutterer endnuMyelomatose | Nydiagnosticeret | MRD | Høj risiko
-
University Hospital, AngersIkke rekrutterer endnu
-
Shanghai Changzheng HospitalCARsgen Therapeutics Co., Ltd.Ikke rekrutterer endnuHøjrisiko Nydiagnosticeret Myelom (HRNDMM)
-
CelgeneBristol-Myers SquibbRekrutteringMyelomatoseØstrig, Forenede Stater, Spanien, Australien, Japan, Frankrig, Israel, Italien, Canada, Grækenland, Belgien, Norge, Rumænien, Tjekkiet, Danmark, Tyskland, Korea, Republikken, Det Forenede Kongerige, Polen
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Janssen Research & Development, LLCIkke rekrutterer endnuLymfom | Myelomatose | Hodgkin lymfom | Myelofibrose | Non Hodgkin lymfom | Kronisk myeloid leukæmi | Hæmatologisk malignitet | Aplastisk anæmi | Myelodysplastiske syndromer (MDS) | Akut myeloid leukæmi (AML) | Afvisning af knoglemarvstransplantation | Akut lymfoblastisk leukæmi (ALL), voksen
-
Peking University First HospitalRekruttering
-
IRCCS Policlinico S. MatteoRekrutteringAL Amyloidose | Monoklonal gammopati af ubestemt betydning | Ulmende myelomatoseItalien
-
Cullinan Therapeutics Inc.Ikke rekrutterer endnu
-
Changzhou No.2 People's HospitalIkke rekrutterer endnu
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Ikke rekrutterer endnuRecidiverende eller refraktært myelomatoseKina
-
Dickran Kazandjian, MDRegeneron PharmaceuticalsIkke rekrutterer endnu
-
Peking University People's HospitalIkke rekrutterer endnuRecidiverende/Refraktær MyelomKina
-
Tufts Medical CenterNational Cancer Institute (NCI)Ikke rekrutterer endnu
-
Wuhan Union Hospital, ChinaIkke rekrutterer endnu
-
Bristol-Myers SquibbRekrutteringMyelomatose | Non-Hodgkin lymfom | Kronisk lymfatisk leukæmiBelgien
-
SanofiIkke rekrutterer endnu
-
Nantes University HospitalJanssen PharmaceuticaIkke rekrutterer endnu
-
Jack KhouriIkke rekrutterer endnuMyelomatose | Refraktær Myelom | Cytokinfrigivelsessyndrom | Immuneffektorcelleassocieret neurotoksicitetssyndromForenede Stater
-
Adriana RossiIkke rekrutterer endnuRecidiverende og/eller refraktært myelomatoseForenede Stater
-
Assistance Publique - Hôpitaux de ParisIkke rekrutterer endnuLymfom, B-celle | Myelomatose | Akut lymfatisk leukæmi | Hæmatologisk malignitet | Bil T- CellFrankrig
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCIkke rekrutterer endnuMyelomatose | Refraktær Myelom | Recidiverende myelomatoseForenede Stater
-
UNC Lineberger Comprehensive Cancer CenterIkke rekrutterer endnuMyelomatose | Nyligt diagnosticeret myelomatose | Autolog stamcelletransplantationForenede Stater
-
Washington University School of MedicineNational Cancer Institute (NCI); The Foundation for Barnes-Jewish HospitalRekrutteringMyelomatose | Endetarmskræft | Cholangiocarcinom | TyktarmskræftForenede Stater
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Ikke rekrutterer endnu